NeoGenomics Inc (NEO)

NASDAQ HEALTHCARE
$11.20 +0.63% RSI 35 Neutral Add Alert

Moving Averages

SMA 200
$9.94
Price above

Company Profile

NeoGenomics, Inc. operates a network of cancer-focused testing laboratories in the United States, Europe, and Asia. The company is headquartered in Fort Myers, Florida.

Sector
HEALTHCARE
Industry
DIAGNOSTICS & RESEARCH
Market Cap
$1.45B
P/E Ratio
None
EPS
$-0.77
Beta
1.811
Dividend Yield
0.00%
52-Week High
$13.74
52-Week Low
$4.72

Similar stocks in DIAGNOSTICS & RESEARCH

TMO
Thermo Fisher Scientific Inc
RSI 46.0
ILMN
Illumina Inc
RSI 56.0
MTD
Mettler-Toledo International Inc
RSI 48.0
CSTL
Castle Biosciences Inc
RSI 51.0
FONR
Fonar Corp
RSI 75.0
CRL
Charles River Laboratories International Inc
RSI 57.0
BDSX
Biodesix Inc
RSI 62.0
NTRA
Natera Inc
RSI 62.0
WGS
GeneDx Holdings Corp - Class A
RSI 57.0
DGX
Quest Diagnostics Inc
RSI 36.0

Data last updated: June 13, 2026 at 4:24 PM EDT

Track NEO for free

Get e-mail RSI alerts when NeoGenomics Inc enters oversold or overbought territory. Free forever.

Add Alert